The effect of hrHPV prevalence on cervical cancer screening strategies: a cost-effectiveness study of Bangladesh

被引:0
|
作者
Pan, Fengming [1 ]
van der Schans, Jurjen [2 ,3 ,4 ]
Nazrul, Naheed [5 ]
Koot, Jaap A. R. [2 ]
Beltman, Jogchum [6 ]
Greuter, Marcel J. W. [7 ]
de Bock, Geertruida H. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
[2] Univ Med Ctr Groningen, Dept Hlth Sci, Unit Global Hlth, Groningen, Netherlands
[3] Univ Groningen, Dept Econ Econometr & Finance, Groningen, Netherlands
[4] Open Univ, Fac Management Sci, Heerlen, Netherlands
[5] Friendship NGO, Hlth Sect, Dhaka, Bangladesh
[6] Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands
关键词
Human papillomavirus DNA tests; Prevalence; Cost-effectiveness analysis; Bangladesh; HUMAN-PAPILLOMAVIRUS INFECTION; CARCINOGENESIS;
D O I
10.1186/s12889-025-21756-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundCervical cancer is the second most prominent cancer among women in Bangladesh, which is mainly caused by persistent infection with high-risk human papillomavirus (hrHPV). This study aims to evaluate impact of hrHPV prevalence on cost-effectiveness of screening with self-sampling hrHPV testing versus visual inspection with acetic acid (VIA) for cervical cancer screening in low- and middle-income countries with Bangladesh as an example.MethodsA micro-simulation Markov model was developed from a health system perspective in Bangladesh to evaluate the cost-effectiveness of screening with self-sampling hrHPV testing followed by VIA and VIA as primary screening method followed by colposcopy. We compared these strategies in optimal (70%) and realistic (8.7%) uptake scenarios, considering different hrHPV prevalence rates. Key indicators for cost-effectiveness were number of prevented cervical cancers cases and incremental cost-effectiveness ratio (ICER).ResultsThe number of cervical cancers cases prevented by screening and cost-effectiveness of screening strategies increased as hrHPV prevalence increased. In both optimal and realistic uptake scenarios, hrHPV test + VIA strategy prevented more cancers than VIA + colposcopy strategy in most instances. Regardless of the uptake, both screening strategies were cost-effective compared to no screening within a hrHPV prevalence range of 2-30%, and the hrHPV test-based strategy was cost-effective compared with VIA-based strategy. When the price of hrHPV test was estimated 50% lower (10 USD), the hrHPV test-based strategy gained more life years at nearly the same cost as the VIA-based strategy.ConclusionsOur study demonstrates that the hrHPV test + VIA strategy is cost-effective both compared to no screening and VIA + colposcopy screening strategy under the optimal (70%) and realistic (8.7%) uptake scenarios, with greater cost-effectiveness at higher hrHPV prevalence levels. While VIA-based strategy is cheaper, self-sampling hrHPV test-based strategy offers greater health benefits. Implementing hrHPV testing in national screening programs at lower hrHPV test prices is crucial for promoting health equity and accelerating cervical cancer elimination worldwide. In resource-constrained settings, screening with hrHPV testing should initially target high-prevalence populations.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] THE COST-EFFECTIVENESS OF MAMMOGRAPHIC SCREENING STRATEGIES
    LINDFORS, KK
    ROSENQUIST, CJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (11): : 881 - 884
  • [22] Probabilistic Cost-Effectiveness Comparison of Screening Strategies for Colorectal Cancer
    Tafazzoli, Ali
    Roberts, Stephen
    Klein, Robert
    Ness, Reid
    Dittus, Robert
    ACM TRANSACTIONS ON MODELING AND COMPUTER SIMULATION, 2009, 19 (02):
  • [23] Cost-effectiveness of colorectal cancer screening strategies: A systematic review
    Gheysariyeha, Fatemeh
    Rahimi, Farimah
    Tabesh, Elham
    Hemami, Mohsen Rezaei
    Adibi, Payman
    Rezayatmand, Reza
    EUROPEAN JOURNAL OF CANCER CARE, 2022, 31 (06)
  • [24] COST-EFFECTIVENESS ANALYSIS OF COLORECTAL-CANCER SCREENING STRATEGIES
    ENGLAND, WL
    HALLS, JJ
    HUNT, VB
    MEDICAL DECISION MAKING, 1986, 6 (04) : 276 - 276
  • [25] A DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS OF SCREENING STRATEGIES FOR OVARIAN CANCER
    Brook, E.
    McNamara, S.
    Hardern, C.
    Metry, A.
    VALUE IN HEALTH, 2022, 25 (12) : S144 - S145
  • [26] Cost-effectiveness analysis of annual screening strategies for endometrial cancer
    Havrilesky, Laura J.
    Maxwell, G. Larry
    Myers, Evan R.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (06) : 640.e1 - 640.e8
  • [27] COST-EFFECTIVENESS ANALYSIS OF COLORECTAL-CANCER SCREENING STRATEGIES
    ENGLAND, WL
    HALLS, JJ
    HUNT, VB
    CLINICAL RESEARCH, 1986, 34 (02): : A363 - A363
  • [28] The cost-effectiveness of cancer screening
    De Koning, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S20 - S21
  • [29] Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC)
    Tsiachristas, Apostolos
    Gittins, Matthew
    Kitchener, Henry
    Gray, Alastair
    JOURNAL OF MEDICAL SCREENING, 2018, 25 (02) : 99 - 109
  • [30] COST-EFFECTIVENESS OF CERVICAL CANCER SCRENNING STRATEGIES AMONG WOMEN IN CAMEROON
    Sormani, Jessica
    Wisniak, Ania
    Kenfack, Bruno
    Datchoua, Alida Moukam
    Vassilakos, Pierre
    Petignat, Patrick
    Combescure, Christophe
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A13 - A14